标题
Current pharmacotherapy for obesity
作者
关键词
-
出版物
Nature Reviews Endocrinology
Volume 14, Issue 1, Pages 12-24
出版商
Springer Nature
发表日期
2017-10-13
DOI
10.1038/nrendo.2017.122
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
- (2017) Carel W le Roux et al. LANCET
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study
- (2017) Fatima Cody Stanford et al. Surgery for Obesity and Related Diseases
- Economic Burden of Obesity: A Systematic Literature Review
- (2017) Maximilian Tremmel et al. International Journal of Environmental Research and Public Health
- Traveling from the hypothalamus to the adipose tissue: The thermogenic pathway
- (2017) Cristina Contreras et al. Redox Biology
- Weight management in obesity - past and present
- (2016) D. Haslam INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Trends in Obesity Among Adults in the United States, 2005 to 2014
- (2016) Katherine M. Flegal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Combining Pharmacological and Psychological Treatments for Binge Eating Disorder: Current Status, Limitations, and Future Directions
- (2016) Carlos M. Grilo et al. Current Psychiatry Reports
- Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder
- (2016) Evdokia Anagnostou et al. JAMA Psychiatry
- Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism
- (2015) Amaia Rodríguez et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The 2013 American Heart Association/American College of Cardiology/The Obesity Society Guideline for the Management of Overweight and Obesity in Adults
- (2015) Caroline M. Apovian et al. CIRCULATION
- Overview of the treatment of binge eating disorder
- (2015) Susan L. McElroy et al. CNS SPECTRUMS
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophrenia
- (2015) Dai Wang et al. Pharmacogenetics and Genomics
- Pharmacogenomics toward personalized tamoxifen therapy for breast cancer
- (2015) Hitoshi Zembutsu PHARMACOGENOMICS
- Obesity and the microbiome
- (2015) Ruchi Mathur et al. Expert Review of Gastroenterology & Hepatology
- Brown and beige fat: the metabolic function, induction, and therapeutic potential
- (2015) Shuwen Qian et al. Frontiers of Medicine
- Medical treatment of obesity: The past, the present and the future
- (2014) George A. Bray BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Increasing frequency of severe clinical toxicity after use of 2,4-dinitrophenol in the UK: a report from the National Poisons Information Service
- (2014) Ashraf Kamour et al. EMERGENCY MEDICINE JOURNAL
- Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes – focus on pancreatitis and pancreas cancer
- (2014) Thor Chalmer et al. Expert Opinion On Drug Safety
- Thyroid safety in patients treated with liraglutide
- (2014) M. Gallo JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Topiramate use in pregnancy and the birth prevalence of oral clefts
- (2014) Daniel Mines et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Obesity Begets Atrial Fibrillation
- (2013) Jared W. Magnani et al. CIRCULATION
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- A prospective, claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs
- (2013) D. Funch et al. DIABETES OBESITY & METABOLISM
- Addiction potential of phentermine prescribed during long-term treatment of obesity
- (2013) E J Hendricks et al. INTERNATIONAL JOURNAL OF OBESITY
- Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
- (2013) T A Wadden et al. INTERNATIONAL JOURNAL OF OBESITY
- Long-term Drug Treatment for Obesity
- (2013) Susan Z. Yanovski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bupropion for Overweight Women With Binge-Eating Disorder
- (2013) Marney A. White et al. JOURNAL OF CLINICAL PSYCHIATRY
- Advantages of percent weight loss as a method of reporting weight loss after Roux-en-Y gastric bypass
- (2013) Ida J. Hatoum et al. Obesity
- Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults
- (2013) Louis J. Aronne et al. Obesity
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Use of Prescription Antiobesity Drugs in the United States
- (2013) Christian Hampp et al. PHARMACOTHERAPY
- Genotype-Based Ancestral Background Consistently Predicts Efficacy and Side Effects across Treatments in CATIE and STAR*D
- (2013) Daniel E. Adkins et al. PLoS One
- Obesity and Cardiovascular Disease
- (2012) Caroline M. Apovian et al. CIRCULATION
- Sibutramine Effects on Central Mechanisms Regulating Energy Homeostasis
- (2012) Joao R. Araujo et al. Current Neuropharmacology
- Unraveling the brain regulation of appetite: lessons from genetics
- (2012) Giles S H Yeo et al. NATURE NEUROSCIENCE
- Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study
- (2012) Patrick M. O'Neil et al. Obesity
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Orlistat and Acute Kidney Injury: An Analysis of 953 Patients
- (2011) Matthew A. Weir ARCHIVES OF INTERNAL MEDICINE
- Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial
- (2011) I. D. Caterson et al. DIABETES OBESITY & METABOLISM
- Pharmacogenomics of Tamoxifen: Roles of Drug Metabolizing Enzymes and Transporters
- (2011) Kazuma Kiyotani et al. Drug Metabolism and Pharmacokinetics
- Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
- (2011) A Astrup et al. INTERNATIONAL JOURNAL OF OBESITY
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- The role of gut hormones and the hypothalamus in appetite regulation
- (2010) Keisuke Suzuki et al. ENDOCRINE JOURNAL
- Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation
- (2010) Lotte Bjerre Knudsen et al. ENDOCRINOLOGY
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
- Brain serotonin system in the coordination of food intake and body weight
- (2010) Daniel D. Lam et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Pharmacogenomics of Tamoxifen Therapy
- (2009) H. Brauch et al. CLINICAL CHEMISTRY
- Appetite control and energy balance regulation in the modern world: reward-driven brain overrides repletion signals
- (2009) H Zheng et al. INTERNATIONAL JOURNAL OF OBESITY
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- Lifestyle Intervention and Metformin for Treatment of Antipsychotic-Induced Weight Gain
- (2008) Ren-Rong Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization
- (2008) W. J. Thomsen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Central and Peripheral Regulation of Food Intake and Physical Activity: Pathways and Genes
- (2008) Natalie R. Lenard et al. Obesity
- Rational Design of a Combination Medication for the Treatment of Obesity
- (2008) Frank L. Greenway et al. Obesity
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation